International Clinical Trial: A global clinical study to test if the medicine Elritercept (KER-050) is effective and safe for treating adults with a type of blood disorder called Myelodysplastic Syndromes (MDS)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104956) titled 'A global clinical study to test if the medicine Elritercept (KER-050) is effective and safe for treating adults with a type of blood disorder called Myelodysplastic Syndromes (MDS)' on Feb. 26.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: Takeda Development Center Americas Inc

Condition: Health Condition 1: D464- Refractory anemia, unspecified

Intervention: ...